PT Pyridam Farma Tbk

Jakarta Stock Exchange PYFA.JK

PT Pyridam Farma Tbk Capital Expenditure for the year ending December 31, 2023: USD -1.54 M

PT Pyridam Farma Tbk Capital Expenditure is USD -1.54 M for the year ending December 31, 2023, a 48.29% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • PT Pyridam Farma Tbk Capital Expenditure for the year ending December 31, 2022 was USD -2.97 M, a 80.87% change year over year.
  • PT Pyridam Farma Tbk Capital Expenditure for the year ending December 31, 2021 was USD -15.54 M, a -2,733.12% change year over year.
  • PT Pyridam Farma Tbk Capital Expenditure for the year ending December 31, 2020 was USD -548.59 K, a -132.99% change year over year.
  • PT Pyridam Farma Tbk Capital Expenditure for the year ending December 31, 2019 was USD -235.46 K, a 83.34% change year over year.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
Loading...
SV Wall Street
Jakarta Stock Exchange: PYFA.JK

PT Pyridam Farma Tbk

CEO Mr. Yan Gwan Lee
IPO Date Oct. 16, 2001
Location Indonesia
Headquarters Sinarmas MSIG Tower
Employees 1,193
Sector Consumers Staples
Industries
Description

PT Pyridam Farma Tbk develops, produces, and sells pharmaceuticals, antibiotics, vitamins, supplements, and traditional herbal care products in Indonesia. The company operates in two segments, Pharmaceutical Products and Toll Manufacturing Services; and Medical Device Products. It offers medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR – extraction kit and extractor machine, speciment bag, sterile container, and tube stopper. The company also provides skin care products comprising Arosa gel, A-Stark Gel, Hymen gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb gel; products in the areas of alimentary t. and metabolism, blood and blood forming organs, cardiovascular system, dermatologicals, G.U. system and sex hormones, systemic corticosteroids, systemic antibacterial, sensory organs, as well as musculo-skeletal, nervous, and respiratory systems; and supplements and other preventive consumer health products with energy drinks and healthy ready-to-drink products. In addition, it engages in the research and development on biotechnology, life, and medical science. The company was founded in 1976 and is headquartered in Jakarta, Indonesia.

Similar companies

MERK.JK

PT Merck Tbk

USD 0.21

0.15%

KAEF.JK

PT Kimia Farma (Persero) Tbk

USD 0.04

-1.52%

MRAT.JK

PT Mustika Ratu Tbk

USD 0.02

-2.09%

TSPC.JK

PT Tempo Scan Pacific Tbk

USD 0.15

-0.70%

StockViz Staff

February 2, 2025

Any question? Send us an email